About Menarini Australia
Our Pipeline

Through a combination of our long-term commitment to research and development and our focus on aggressively pursuing in-licensing opportunities, Menarini’s unique business model has delivered for us a strong pipeline that continues to facilitate our entry into additional therapeutic areas.

This approach is the platform for our rapid growth trajectory and Menarini Australia is poised to significantly increase its footprint with at least six new product launches planned over the next five years.

Moreover, Menarini Australia’s association to its parent company, the Menarini Group, gives it access to an international network of R&D infrastructure and global partnerships.

In expanding our reach, we aim to bring to patients the new and novel treatment options required to address some of the world’s most challenging diseases.

Our research and development activities are currently focused on the following therapeutic fields:

  • Cardiovascular
  • Gastroenterology
  • Antibiotics and Respiratory
  • Diabetes
  • Anti-inflammatories
  • Analgesics

For more information about Menarini Group’s research laboratories, please visit: http://www.menarini.com/Home/Our-Group/The-research-centres.